ViewRay Profit Margin

The latest profit margin for VRAY is -107.85% as of March 2023. That compares with -146.15% in the prior-year period — up 26.2% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside ViewRay's historical trend and sector peers before judging valuation or financial health.

Over the past year, VRAY's profit margin moved from -146.15% to -107.85% — a 26.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ViewRay's valuation or profitability profile.

Against Healthcare companies, VRAY currently prints -107.85% for profit margin, while the sector average sits near 21.34%. That is roughly 605.5% below the sector mean. Large gaps often invite a closer look at ViewRay's growth, margins, and balance sheet.

Profit Margin shows how effectively ViewRay converts resources into returns. At -107.85%, VRAY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -146.15% in the prior-year period — up 26.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VRAY's profit margin (-107.85%), review year-over-year change from -146.15%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.